Montgolfier Research

Semper Sursum (Always Upward)

Featured Research

AI Infrastructure / Data CentersEvent-driven thesis

Digipower Technologies (NYSE American: DGXX)

Montgolfier Research — Research Thesis

Released: December 23, 2025Ticker: DGXXRead time: 25 min read

Key Takeaways

  • Binary valuation inflection expected Q1 2026
  • Contract confirmation likely triggers re-rating from ~2x to ~8x EV/Revenue
Read the Report

More Research

Commodities / EnergySector thesis

Uranium — Market Research

The 2026 squeeze and the structural reset

Released: January 9, 2026Read time: 30 min read

Key Takeaways

  • 2026 timing mismatch: mines slow, utilities forced to replace fuel
  • Two forces: nuclear renaissance (structural) + mechanical squeeze (procurement)
Read the Report
Market OpportunitiesSector thesis

Venezuelan Oil — Market Opportunities

Market Opportunities provided by Montgolfier Research

Released: January 9, 2026Read time: 20 min read

Key Takeaways

  • Regime shock changes direction, not constraints
  • Upstream is slow/CapEx-heavy; logistics + refining reprice earlier
Read the Report
Merger ArbitrageEvent-driven (Short-term)

MGO Global Inc. (MGOL)

Merger Opportunity — Due Diligence Report

Released: January 31, 2025Ticker: MGOLRead time: 15 min read

Key Takeaways

  • MGOL merging with Heidmar Inc. valued at $300M; MGOL shareholders projected to own $18M equity
  • Current MGOL market cap ~$10M vs $18M equity value = potential 80%+ upside
Read the Report
PharmaceuticalsEvent-driven (Short-term)

Sonoma Pharmaceuticals (SNOA)

Due Diligence — Gross Undervaluation Play

Released: January 31, 2025Ticker: SNOARead time: 12 min read

Key Takeaways

  • Potential catalyst: Press release expected following 8K notice on new US distribution agreement
  • Gross undervaluation: Negative enterprise value of -$463,000 despite strong Q3 2024 growth
Read the Report
BiotechnologyEvent-driven (Short-term)

FibroBiologics (FBLG)

Due Diligence — Catalyst Play with Institutional Backing

Released: February 6, 2025Ticker: FBLGRead time: 15 min read

Key Takeaways

  • BlackRock purchased $2,871,952 worth of shares at ~$2.20 — major institutional confidence signal
  • Upcoming catalyst: Investor conference Feb 10-11 with 'research & development updates'
Read the Report
PharmaceuticalsEvent-driven (Short-term)

Lexicon Pharmaceuticals (LXRX)

Due Diligence — Phase 2b Catalyst Play

Released: February 13, 2025Ticker: LXRXRead time: 20 min read

Key Takeaways

  • Phase 2b topline data for LX9211 expected between Feb 18 - March 31, 2025
  • Previous catalysts drove 40-50% stock price appreciation
Read the Report

About Montgolfier Research

At Montgolfier Research, our mission is to uncover undervalued companies on the verge of transformative growth. Inspired by the pioneering spirit of the Montgolfier brothers—who soared when others stayed grounded—we conduct rigorous, in-depth research to spotlight hidden gems poised for major catalysts. By sharing our findings ahead of crucial market moments, we empower you with compelling information to explore new opportunities.